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Abstract 
 
The current standard of treatment for the failure of small diameter (<5 mm ID) blood vessels is 
bypass surgery using biological or synthetic grafts. However, these grafts have limitations, such as the 
secondary wound site caused by autologous sources. Tissue engineered vascular grafts (TEVGs) are a 
promising alternative because they could be non-immunogenic, vasoactive, customizable, and have an 
off-the-shelf availability. Previous studies have shown that a bioreactor can condition TEVGs to meet 
these ideals. A bioreactor is a device that simulates an in vivo environment to improve the structure and 
function of engineered tissues. TEVGs should be cultured in a dynamic environment that provides 
luminal laminar flow. These conditions facilitate nourishment of the cells and prevent occlusion of the 
graft. In this study, we designed, manufactured, and validated a novel bioreactor system for TEVGs. The 
bioreactor design successfully provided luminal laminar flow, incorporated an isolated flow loop, 
prevented leakage, remained sterile, limited mounting time, accommodated different sized samples, was 
easy to machine and cost effective. 
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Chapter 1: Introduction 
 
When a blood vessel becomes diseased or obstructed, it cannot transport blood through the circulatory 
system properly. The medical standard for replacing small diameter (<5 mm inner diameter) blood vessels 
is to use a bypass graft (Nerem & Seliktar, 2002). In the United States, about 500,000 coronary artery 
bypass graft surgeries are performed annually (Rosamond et al., 2008). Bypass graft surgery is a surgical 
procedure in which blood flow is rerouted around the damaged vessel, generally performed using an 
autologous graft - a transplanted vein or artery from the body of the patient (Sales et al., 2005). Medical 
professionals also use grafts in patients with kidney failure, who often need dialysis treatment to remove 
waste and excess water from the blood. A surgeon joins an artery and a vein with a tubular graft, which 
creates an artificial high-flow vessel for dialysis (Kawecka, 2008). Dialysis grafts are generally needed 
for patients with smaller diameter blood vessels because they are the least accessible and require a higher 
volumetric flow rate (Dardik et al., 1996). 
Unfortunately, suitable autografts are not available in one-third of patients due to previous surgeries 
and other preexisting vascular conditions (Beamish, Kottke-Marchant, & Marchant, 2010). Autologous 
grafts also create a secondary wound site, consequently increasing the patient’s recovery period (Engbers-
Buijtenhuijs et al., 2006). Finally, the mechanical properties of the autologous grafts may be different 
from the vascular tissue of the affected area due to structural differences between veins and arteries (He et 
al., 2010). 
In order to address the limitations of autografts, researchers are currently investigating tissue 
engineered vascular grafts (TEVGs) as an alternative. TEVGs would eliminate the secondary wound site 
created by autografts, more accurately mimic native tissue, and provide “off-the-shelf” availability to 
surgeons. Researchers in Professor Marsha Rolle’s laboratory at Worcester Polytechnic Institute (WPI) 
are developing methods to create TEVGs, but these samples show lower suture retention and burst 
pressure strengths compared to natural blood vessels (Doshi, 2009). By culturing TEVGs in a bioreactor 
that simulates the in vivo environment, they would more accurately mimic native vascular tissue (Bjork & 
Tranquillo, 2009). 
The goal of our project was to design a novel bioreactor to provide luminal laminar flow and a 
constant shear stress to the TEVG. Luminal flow will improve nutrient and waste transportation and shear 
stress will ensure uniform luminal cell growth (Engbers-Buijtenhuijs et al., 2006). Constant shear stress is 
a result of an organized flow pattern without the mixing of fluid layers, also known as laminar flow 
(Traub & Berk, 1998). In addition to luminal laminar flow, the bioreactor must have isolated flow loops, 
remain sterile, limit mounting time, be easy to machine, and accommodate different sized samples. 
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Currently, the laboratory is using a bioreactor designed in 2011 that does not currently meet these 
objectives. 
We began this project by conducting a literature review on vascular physiology, tissue engineering, 
biofluid mechanics, and the current state of TEVG and bioreactor technology. Using an initial client 
statement, client interviews, and the literature review, we developed a set of design criteria. We organized 
these criteria into constraints, objectives, functions, and specifications. After ranking the criteria by 
importance, we developed conceptual design alternatives. We created preliminary prototypes of the 
alternative that best addressed the criteria. After several iterations of the initial prototype, the device 
evolved into the final design presented in this report. We developed experiments that addressed each of 
the design criteria to determine the success of the device. The results of the experimental testing were 
then used to make final recommendations to the design. In this project, we created a functional bioreactor 
that could provide luminal laminar flow of media to a TEVG created in the Rolle laboratory.  
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Chapter 2: Literature Review 
 
This chapter presents information that is necessary to understand the need and purpose of our project. 
It discusses the physiology of vascular tissue, the importance of TEVGs, the culturing methods, the media 
flow requirements, and the different types of bioreactors for TEVGs currently available.  
 
2.1: Vascular Physiology 
 
The main function of the cardiovascular system is the transportation of nutrients, gases, hormones, 
waste products and other biological compounds to and from all cells in the human body. This is especially 
important in maintaining homeostasis (Berne & Sperelakis, 1979). The cardiovascular system is 
composed of the heart, the lungs, and blood vessels. The blood is oxygenated in the lungs and circulated 
systemically through the rest of the body, providing the oxygenated blood to the cells (Raines, 
Noordergraaf, & Baan, 1978). Blood is transported via three types of vessels: arteries, veins, and 
capillaries. 
Arteries and veins are composed of three layers: the tunica intima, tunica media, and tunica 
adventitia, shown in Figure 1. The innermost and thinnest layer is the tunica intima, located on the lumen 
of the blood vessel (Fox, 2001). It consists of a single layer of endothelial cells surrounded by a thin layer 
of elastic tissue called the internal elastic lamina (Ryan, 1988). The middle layer is the tunica media, 
which is composed of SMCs and elastin. The media layer is responsible for the vasodilation and 
vasoconstriction of the blood vessels (Mohrman, 2003). This layer is thicker in arteries than veins because 
the pressure of the blood flow is higher in arteries (Camilleri, 1989). The tunica adventitia is the 
outermost layer and is made mainly of collagen and fibroblasts. This serves to anchor and stabilize the 
vessel to the surrounding tissue (Thrillet, 2008). Because veins do not have a supportive media layer due 
to low blood pressure, veins require stability from the adventitia layer, and therefore it is thicker in veins 
(McDonald, 1979). Developing a TEVG that models the structure of native tissue would allow the TEVG 
to mimic native mechanical properties.  
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Figure 1: Blood vessel structure 
 
2.2: Importance of Tissue Engineered Vascular Grafts 
 
The heart pumps about 2,000 gallons of oxygenated, nutrient-rich blood throughout the body each 
day (Khan, Farah, & Domb, 2012). Plaque build-up, known as atherosclerosis, in the coronary arteries 
can cause restricted blood flow to the heart and can lead to coronary artery disease (CAD), a major cause 
of death in the United States (Thompson et. al., 2002). The non-linear geometry of the coronary arteries 
causes increased incidences of atherosclerosis (Chiu & Chien, 2011). There are multiple methods of 
restoring blood flow in the veins and arteries including bypass graft surgery, or the rerouting of blood 
around a damaged vessel. This is one of the most common procedures used clinically. (Khan et al, 2012) 
Coronary artery bypass graft (CABG) surgery uses an artery or vein from another source to bypass an 
affected artery. In the United States alone there are approximately half a million CABG surgeries 
performed each year (Rosamond et. al., 2008). The saphenous vein in the leg, mammary artery in the 
chest, and the radial artery in the arm are the conventional sources for grafts. However, these sources are 
limited because patients have a limited number of potential blood vessels for use in grafts and the grafts 
may not have the same mechanical properties as the vessel that is being bypassed (Subramanian & 
Abhilash, 2009).These surgeries also create a secondary wound site which can prolong the length of 
recovery time. Consequently, these limitations create a need for the development of TEVGs. Advantages 
of using TEVGs include the ability to be customized to the patient’s needs, the possibility of reducing the 
immunogenic response, and the capacity to provide an off-the-shelf availability to surgeons. Unlike 
synthetic grafts, TEVGs can have a biological component that will allow the graft to repair itself and 
exhibit contractile properties (Pankajakshan & Agrawal, 2010). 
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2.3: Current State of Culturing Tissue Engineered Vascular Grafts  
  
TEVGs can be created in a laboratory setting using various methods. The method for culturing 
TEVGs varies by laboratory, and different processes have yielded differing results in culture time, suture 
retention testing, and burst pressure testing (Doshi, 2009 & L'Heureux et al. 1998). Suture retention and 
burst pressure testing are important indicators of mechanical properties. Suture retention strength is the 
amount of tensile load that is applied on a suture through a material at the point of failure. Burst pressure 
strength is the maximum pressure the graft can withstand before rupturing. The benchmark for this testing 
is natural blood vessels. Exhibiting the same mechanical properties as a native blood vessel is the most 
important objective when culturing TEVGs (Li, L’Heureux, & Elisseeff, 2011). In this section, we will 
discuss two methods of culturing TEVGs: the tissue rolling method and direct cell seeding method. We 
chose to discuss these two methods because the tissue rolling method grafts are currently being used in 
clinical trials and the direct cell seeding method is currently used in the Rolle laboratory. 
 
2.3.1: Tissue Rolling Method 
  
One method used to create TEVGs is known as the tissue rolling method in which SMCs are cultured 
in a sheet, rolled onto a mandrel, and cultured into a tube. The SMC layers fuse together to form a single 
layer. This SMC layer can be covered with a fibroblast layer using the same method. The SMC layer of 
the TEVG mimics the media layer of natural tissue, and the fibroblast layer mimics the adventitia layer. 
This process is illustrated in Figure 2. (L’Heureux et al., 1998) 
 
 
Figure 2: Tissue rolling method 
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Results from burst pressure testing and suture retention testing show that TEVGs cultured using the 
tissue rolling method have similar mechanical properties to natural tissue. The mean burst pressure 
strength is 3517 mmHg for a 5.5 mm inner diameter graft created using the rolling method (L’Heureux et 
al., 1998). The culture time for the tissues is usually three months (L’Heureux et al., 2007). This 
diminishes the availability of the TEVG and increases production costs. In addition, for TEVGs cultured 
using the tissue rolling method, the mechanical strength comes from the fibroblast adventitia layer, not 
the media layer, as in natural tissue (L’Heureux et al., 1998).  
 
2.3.2: Direct Cell Seeding Method 
  
Researchers in Prof. Rolle’s laboratory are developing an alternative method, in which SMCs are 
seeded directly on to a silicone mandrel. Silicone support rings are placed on a well plate and silicone 
tubes are placed over the rings. A cell suspension of SMCs is then pipetted into the center of each support 
ring. The plates are inverted and cultured in an incubator for 30 minutes. They are then removed from the 
incubator, turned upright, and the cellular suspension is aspirated. The wells are filled with media and 
cultured for fourteen days to allow the cells to proliferate and deposit an extracellular matrix. This process 
is illustrated in Figure 3. (Doshi, 2009) 
 
 
Figure 3: Direct cell seeding method (Doshi, 2009) 
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This method successfully creates TEVGs in a shorter period, although they are not as strong as those 
created by the tissue rolling method. One limitation of the direct cell seeding method is the diffusion 
limit. When the TEVGs reach a thickness of 250 µm, nutrients can no longer diffuse through the outer 
surface to the lumen, causing necrosis of the luminal tissue (Doshi, 2009). The TEVGs usually reach this 
point at about 12 days in culture. The diffusion limit restricts the amount of time the TEVGs can be 
cultured, which negatively affects the mechanical properties of the graft. The burst pressure strength of 
TEVGs cultured using the direct cell seeding method is about 255 mmHg, a degree of magnitude lower 
than that of natural blood vessels, discussed further in the next section (Doshi, 2009).  
Previous studies have shown that a bioreactor can be used to condition grafts to imitate native tissue 
(Bjork & Tranquillo, 2009). A bioreactor is a device that simulates an in vivo environment. For vascular 
tissue, flow of cell culture media through the lumen simulates blood flow through natural vessels. A basic 
schematic of a bioreactor is shown in Figure 4. It incorporates a pump that moves media through the 
lumen of the TEVG and a reservoir of media that provides nourishment to the outer surface of the graft. 
The fluid dynamics of the media are important to consider in the development of a bioreactor for TEVGs. 
 
 
Figure 4: Basic bioreactor system 
 
2.4: Flow and Shear Stress 
 
A laminar luminal flow bioreactor is needed to continue the growth and development of three-
dimensional TEVGs. Laminar flow is the movement of a fluid without the mixing of layers, and ideally 
forms a parabolic flow profile as shown in Figure 5. Laminar flow is responsible for imparting constant 
shear stresses against the wall of the container it is flowing in, in this case the lumen of the TEVG. The 
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wall of the TEVG needs this constant shear stress in order to mimic the in vivo environment (Brooks, 
Lelkes, & Rubanyi, 2002).  
 
 
Figure 5: Laminar and turbulent flow 
 
Shear stresses caused by laminar flow are essential for the growth and development of vascular tissue 
(Traub & Berk, 1998). A constant shear stress is needed for the survival and orientation of endothelial 
cells that line the lumen of the blood vessel (dela Paz et al., 2012). In a study done by Nathaniel dela Paz 
et al. at Harvard Medical School, it was shown that a constant shear stress decreased apoptosis in human 
umbilical vein endothelial cells (HUVECs) by increasing the production of vascular endothelial growth 
factor (VEGF) in arterial cells. This protein has many functions in the cardiovascular system, including 
angiogenesis (dela Paz et al., 2012). Since a constant shear stress is necessary for the growth and 
development of TEVGs, laminar flow is required in our bioreactor.  
The shear stress imparted on the wall of an idealized tube by the movement of a viscous fluid can be 
calculated using Equation 1. Turbulent flow causes inconsistent shear stresses on the lumen, which can 
lead to varying wall thicknesses along the length of the vessel (Brooks, Lelkes, & Rubanyi, 2002). This 
turbulence can also cause destruction of the endothelial layer and eventually lead to vascular diseases 
such as atherosclerosis (Zhixin et al., 2011). Turbulence is usually not found in straight blood vessels in 
vivo, but can be found at bends in vascular architecture, as seen in coronary arteries (Traub & Berk, 
1998). The TEVG can be damaged or have a varying wall thickness if turbulent flow is found in the 
bioreactor’s flow loop. Shear stress on vascular tissue in vivo ranges from 10-40 dynes/cm2 (Resnick et 
al., 2003). Using a known shear stress, the velocity of a fluid through a tube can be calculated. 
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Equation 1: Calculation for shear stress: τ is shear stress, µ is dynamic viscosity of the fluid, U is mean velocity of the fluid, and 
D is the inner diameter of the pipe. 
 
  
   
 
 
 
Because we are designing a bioreactor system for a known shear stress in the TEVG, the dependent 
variable in Equation 1 is velocity (U). Using the inner diameter of the TEVG and the calculated velocity, 
we can calculate the flow rate of the entire system using Equation 2. The flow rate will remain constant 
no matter what size tube the fluid is flowing in order to have the desired velocity in the TEVG. 
 
Equation 2: Flow rate calculation: U is velocity of fluid, and A is cross sectional area of the tube in which fluid flows 
 
     
 
The flow profile in our bioreactor can be determined by calculating the Reynolds number of the fluid 
flowing through the TEVG. The Reynolds number is a dimensionless metric that can be calculated to 
determine whether the flow of a viscous fluid in a tube is laminar or turbulent. If the Reynolds number is 
less than 2100, then the flow is laminar (Waite & Fine, 2007). If we assume the tube is rigid with a 
constant diameter and the fluid flow rate is constant, we can calculate the Reynolds number using 
Equation 3. The limitations of this assumption are discussed in Chapter 6. 
 
Equation 3: Reynolds number where: ρ is the density of the fluid, U is the velocity of the fluid, μ is the dynamic viscosity of the 
fluid, and D is the inner diameter of the tube. 
 
   
   
 
 
 
Another important consideration for laminar flow is entrance length. Entrance length is the length of 
tube that is necessary for the development of laminar flow. The development profile is illustrated in  
Figure 6. The calculation for entrance length is shown in Equation 4. 
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Figure 6: Development of laminar flow 
 
Equation 4: Entrance length, where Le is entrance length, Re is Reynolds number in the tube, and D is inner diameter of the tube. 
 
              
 
We found that there was a lack of published data regarding the effect of shear stress on three-
dimensional constructs purely derived from SMCs. Many articles reported on the effect of shear stress on 
ECs because only ECs are exposed to flow in vivo. In order to predict the effect a laminar flow bioreactor 
would have on the TEVGs, we considered the effect of shear stress on two-dimensional SMC sheets to 
predict the effect on three-dimensional grafts. 
In 2006, Wang et al. reported that shear stress could induce EC transdifferentiation of mouse SMCs. 
Mouse SMCs were cultured to 80% confluence and exposed to laminar fluid shear stress via a parallel 
plate flow chamber. The SMCs were exposed to a steady shear stress of 15 dynes/cm
2
 for 6, 24, and 48 
hours. At each time point, Wang et al. extracted RNA, which they reverse transcribed into cDNA. They 
used PCR to assess mRNA levels of murine platelet-endothelial cell adhesion molecule-1, von Willebrand 
factor, and VE-cadherin. These markers were chosen because they are expressed by ECs (Wang et al., 
2006). They also used PCR to test for SMC markers, specifically alpha-smooth muscle actin, calponin-1, 
and smooth muscle myosin heavy chain. The results of this experiment showed that after exposure to a 
laminar fluid shear stress for 24 and 48 hours, SMC exhibited increased EC markers and decreased SMC 
markers, including alpha-smooth muscle actin. They also observed increased cell alignment in the 
direction of the flow after 24 and 48-hour flow exposure period compared to the statically cultured SMCs. 
Wang et al. concluded that shear stress might promote endothelial cell transdifferentiation from SMCs. 
This finding was corroborated by a study conducted in 2010, which indicated that when SMCs were 
exposed to shear stress of 14 dynes/cm
2
 for 24 hours, had decreased transcription of endothelin, a protein 
associated with constriction of blood vessels (Ekstrand, 2010). This is logical because if the endothelial 
layer of a blood vessel were damaged in vivo, the hemodynamic environment would alter the gene 
expression of SMCs to repair the damage. (Wang et al., 2006) 
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Fitzgerald et al. reported in 2007 that laminar shear stress stimulates vascular smooth muscle cell 
apoptosis. Bovine aortic SMCs were cultured in a sheet and exposed to 11 dynes/cm
2
 for 24 hours. These 
dynamically cultured SMCs were compared to SMCs exposed to static media. They found that the SMCs 
exposed to shear stress had 38% fewer cells, a 15-fold increase in TUNEL staining, a 3-fold increase in 
caspase-3, and a 67% decrease in Akt phosphorylation. TUNEL is a method that detects DNA 
fragmentation due to apoptosis. Caspase-3 is a member of a protease family that plays an essential role in 
the execution phase of apoptosis. Akt is a protein kinase that inhibits apoptosis. The results of this 
experiment indicate that SMCs exposed to shear stress have decreased cell proliferation and increased 
apoptosis. Considering in vivo applications of this discovery, increased SMC apoptosis would prevent 
stenosis of the blood vessel by limiting SMC proliferation. (Fitzgerald et al., 2007) 
Although this research is based on two-dimensional SMC samples, we anticipate similar results on 
three-dimensional grafts. We hypothesize that a luminal laminar flow bioreactor providing shear stress 
would decrease levels of alpha-smooth muscle actin, align SMCs in the direction of flow, and prevent 
luminal occlusion. 
 
2.5: Current Technology 
 
Presently, there many different types of bioreactor designs used in research settings. Many of these 
designs are custom made and tailored to the specific nature of the experiments being conducted. As such, 
bioreactor designs can vary from laboratory to laboratory. Bioreactors can be used to culture either two-
dimensional or three-dimensional samples. This chapter will focus on three-dimensional bioreactor 
designs; two-dimensional bioreactors are beyond the scope of this report.  
 
2.5.1: Cerulli et al. Bioreactor 
 
Prof. Rolle’s laboratory currently uses a laminar luminal flow bioreactor to aid in culturing TEVGs. 
This bioreactor incorporated mounts for the TEVG that were located on the underside of the lid, shown in 
Figure 7. The graft, depicted in red, was sutured between these two needle mounts. One arm (A) was 
adjustable, allowing the user to easily suture the sample to both needle mounts and adjust them 
accordingly. The mobile arm was kept in place with a magnet, while a track allowed for stability, labeled 
B in Figure 8. Media flowed into the bioreactor through the inlet on the left. It then went through the 
lumen on the graft and emptied into the reservoir after passing through the mobile arm A. Media flowed 
from the reservoir through the outlet on the right, back to the pump. A photograph of the bioreactor’s lid 
is shown in Figure 9. 
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Figure 7: Previous bioreactor design, isotropic view with mobile arm (A) 
 
Figure 8: Previous bioreactor, underside of lid with track (B) 
 
 
Figure 9: Cerulli et al. lid, which includes the stationary mount (A), the removable mount (B), luer connector (C), track for 
removable mount (D), and the needle mounts (E) 
B 
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The novel design of the Cerulli et al. bioreactor allowed it to accommodate different sized samples 
and made mounting the TEVG easier for the user. However, this design is not without limitations. The 
Cerulli et al. bioreactor does not have isolated flow loops. This means the media that passes through 
lumen mixes with the media in the reservoir. This restricts the user to using the same type of cell culture 
media for the lumen of the TEVG as well as the exterior. Additionally, the mobile arm of the bioreactor is 
susceptible to unwanted movement during the culture period. Although the design uses a set of tracks to 
prevent motion of the magnetized mobile arm, they are sometimes ineffective. This causes the 
misalignment between the mobile arm and the fixed arm. Misalignment disrupts laminar flow and causes 
turbulence and uneven shear stress. The inlet and outlet ports to the reservoir are below the media level. 
Because the connection points are not completely sealed, leakage occurred inside the incubator, shown in 
Figure 10. A gap between the lid and the reservoir, denoted with the arrow, was designed to let the user 
connect the silicone tubing to the inlet port of the luminal flow loop. This gap allows air to contact the 
reservoir of the bioreactor directly, increasing the chance of contamination. Media leaks from the gap 
when the bioreactor is moved from the biosafety cabinet into the incubator. 
 
 
Figure 10: Cerulli et al. bioreactor leakage 
 
 
 
14 
 
2.5.2: Banes et al. Bioreactor  
 
Professor Albert Banes from the University of North Carolina holds the patent for a unique bioreactor 
design, which includes a novel mounting device and can be adjusted to accommodate a wide range of 
sample sizes. We considered the mounting device of this design as an alternative to using sutures to 
mount the TEVG to the luminal flow loop of the bioreactor because of the potential to reduce the 
mounting time of each sample. Reducing the mounting time is critical because the TEVG is not in cell 
culture media during the mounting process and cell death can occur if the TEVG is without cell media for 
too long. (Banes, Wang, Qi, & Kheradpir, 2004) 
The mounting device, shown in Figure 11 and Figure 12, has three main components. In Figure 12, 
the attachment site for the TEVG is labeled A. The TEVG is slid over this cylindrically shaped 
component and over the small grooves beyond the tip, which secure the TEVG in place. Each mount has 
four arms that fix the TEVG in place. Each arm can be set to one of two possible positions: open and 
closed. In the open position, the arm extends away from the mounting device to provide the operator with 
enough room to mount the sample. In the closed position, a small curved area of the arm contacts the 
sample and applies pressure, labeled B. These arms are positioned perpendicular to each other so that they 
contact the sample radially every 90⁰. Constant uniform pressure is applied to the sample via an O-ring, 
labeled C. The O-ring can be positioned such that it fits into a grooved slot on each of the arms; the 
grooved slot is labeled D. The O-ring prevents arms from disengaging the sample during the experiment. 
To remove the sample, the O-ring is slid out of the groove, the arms are extended to the open position, 
and TEVG is carefully slid off the mount. This mounting mechanism is mirrored on the other end of the 
bioreactor. (Banes, Wang, Qi, & Kheradpir, 2004)  
 
 
Figure 11: Banes mount open 
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Figure 12: Banes mount closed 
 
The main disadvantage of this mounting mechanism is that it destroys the cells at the ends of the 
sample. The pressure required to fix the TEVG to the mount crushes the cells at that location. This would 
require that these sections be removed before the results can be analyzed. Another possible complication 
with this design is that the TEVG may tear if the tissue becomes caught in the grooves on the mount as its 
being removed. Because of the size and complexity of the mechanism, it could be difficult and costly to 
machine. (Banes, Wang, Qi, & Kheradpir, 2004) 
The other unique feature of this design is the mechanism for adjusting the distance between the two 
mounts to accommodate different sized samples. The gear mechanism with a knob allows the operator to 
set the distance between the mounts manually, shown in Figure 13. When the knob, labeled A, is turned 
by the operator, it simultaneously moves both ends of the mounting device. The sample is housed in a 
media-filled reservoir, labeled B. The reservoir is the main limiting factor in the accommodation of 
different sized TEVGs in the bioreactor. (Banes, Wang, Qi, & Kheradpir, 2004)  
 
 
Figure 13: Banes adjustable mount mechanism: knob (A) and reservoir (B) 
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A limitation of this design is that the distance between the mounts can only be adjusted in discrete 
intervals. This could be a problem if a sample requires a distance that is between two intervals. However, 
as long as the intervals are kept small enough this issue can be avoided in most cases. Another limitation 
of this bioreactor is the complexity of the small parts. This increases the possibility that errors could be 
made during manufacturing. Additionally, the size of the TEVG is limited by the length of the well, 
shown in Figure 13, labeled B. This device also has a large footprint, which would affect how many 
TEVGs can be cultured in an incubator at the same time. (Banes, Wang, Qi, & Kheradpir, 2004) 
 
2.5.3: Williams & Wick Bioreactor 
 
Chrysanthi Williams from Georgia Institute of Technology published a design for a modular 
bioreactor. This bioreactor, unlike many other designs, was intended to culture several samples per trial. 
The entire bioreactor is made from glass, which allows for durability during autoclaving. The Williams & 
Wick bioreactor design has two main components: the individual modules and the head plate where each 
module is attached in parallel. The module has both luminal flow and exterior flow. Each module is 
cylindrically shaped with mounts penetrating into the interior of the cylinder. The module does not have 
adjustable mounts as in the Banes et al. design. The ends of the sample are mounted using sutures. 
Modules can be connected to one another via interlocking head plates. An O-ring is used to compress 
each module together, forming a tight seal. The media flows through the lumen top down while the 
exterior flow goes from left to right. This design enables the incubation of several samples at one time. 
The number of samples that could be placed in parallel is limited by the number of available modules, the 
size of the incubator, and available cell culture media. (Williams & Wick, 2004) 
Suturing the TEVG to the mounts is difficult in the Williams & Wick design because the mounts are 
fixed in place. It also requires the researcher to produce consistently sized tissue samples. If the samples 
are too small, they could not be sutured to the mounts. If they were too big, then too much of the TEVG 
would be covering the mount. The tissue that overlapped on the mount would most likely be unusable. It 
is also possible the sample is simply too large to fit onto the module mounts.  
The Williams & Wick bioreactor is made from hand blown glass. While this increases the production 
cost of the bioreactor, it does provide several advantages. The glass will not deform after multiple 
autoclaving cycles (Williams & Wick, 2004). The durability of this design makes it a good investment for 
long-term use. It also has very few ways in which it can fail because it has no moving parts. If the device 
were to fail, it would most likely be due to leakage because of incorrectly fabricated parts. If the modules 
do not line up exactly, there is a high probability that leakage from the exterior flow loop will occur. 
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The limitations of autologous and synthetic grafts used to treat diseases, such as atherosclerosis, 
create a need for TEVGs. By reviewing the literature, we were able to develop a greater understanding of 
the importance of tissue engineering and the biofluid mechanics necessary in a bioreactor system. We also 
researched other novel bioreactor designs that addressed a similar need to that created by the TEVGs 
cultured in the Rolle laboratory. We then developed our project strategy to design a bioreactor that 
provides luminal laminar flow to a TEVG.   
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Chapter 3: Project Strategy 
 
The first step in designing the bioreactor was organizing the client’s needs into constraints, 
objectives, functions, and specifications. The constraints were the strict limits that the bioreactor design 
must have met in order to be successful. The objectives identified the desired attributes of the bioreactor 
design. Lastly, the functions were the actions the bioreactor must perform and the specifications are the 
quantitative requirements related to the functions. We determined these design criteria using the client 
statement, client and user interviews, and literature research. The following chapter describes each of the 
constraints, objectives, functions, and specifications of the bioreactor.  
 
3.1: Initial Client Statement 
 
When we first started the project, the client provided us with the following statement: 
 
“Bioreactors have been shown to improve the structure and function of engineered tissues by 
providing conditions that simulate the in vivo environment in which the tissue normally exists. In 
addition, bioreactors can facilitate seeding, organization and culture of cells to support tissue growth and 
maturation. For tissue engineered blood vessels, bioreactors that provide flow of cell culture medium 
through the center (lumen) of the blood vessel allow seeding of endothelial cells, nutrient diffusion to 
cells near the lumen of the vessel, and application of shear stress to endothelial cells lining the vessel. In 
addition, bioreactors must provide appropriate mechanical stimulation to facilitate the culture and 
development of tissue-engineered blood vessels that match the structural, physiological, and mechanical 
properties of normal vascular tissue. Previous MQP teams have designed and tested two individual 
bioreactor systems - one that provides luminal flow, and on that imparts cyclic mechanical distension. 
The goal of this project is to create a novel bioreactor system that incorporates both luminal flow and 
appropriate mechanical conditioning for vascular tissue engineering. The bioreactor must securely 
anchor the tissue sample without damage or leaking. Ideally, the bioreactor should be inexpensive and 
easy to manufacture, such that multiple samples can be cultured in a single experiment.” 
 
3.2: Current Device – Cerulli et al. Bioreactor 
 
The previous MQP group had successfully designed a bioreactor for three-dimensional TEVG 
constructs cultured using the direct cell seeding method. The previous design was sterilizable, provided 
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luminal flow to the TEVGs, and incorporated an adjustable mount to increase ease of mounting. Although 
it is functional, there were problems with the device that needed to be addressed. The previous bioreactor 
design had many different parts and connections, causing a large volume of media leakage and 
compromised sterility. Post-manufacturing modifications, namely the shortened needle mounts, did not 
allow enough entrance length to allow laminar flow to develop. In addition, the laminar flow bolus test 
performed on the device was inconclusive. Considering the advantages and disadvantages of the previous 
design, we created another iteration of a laminar luminal flow bioreactor for TEVGs. 
 
3.3: Design Constraints 
 
In order to design a bioreactor that satisfied the needs of our client, we first needed to identify and 
meet all of our constraints. The constraints of the design were that is provide luminal flow, securely 
mount the tissue sample, permit gas exchange, fit inside incubator, be sterilizable, be within a $496 
budget, and be completed within the 28-week time frame. The users of the bioreactor are Prof. Rolle, Zoe 
Reidinger, and WPI students working in the Rolle laboratory. 
Providing luminal flow through the TEVG was required for the development of viable tissue samples. 
Luminal flow is important because it prevents necrosis in the inner surface of the TEVG by allowing for 
the transportation of nutrients and waste to and from the lumen (Engbers-Buijtenhuijs et al., 2006). 
In addition to the flow constraints, the bioreactor also needed to meet operational constraints. First, 
the mounting mechanism needed to be able to attach the TEVG securely in such a way that would permit 
media to flow through the lumen and provide media to the exterior surface. We also determined that the 
bioreactor must securely mount the sample without causing extensive damage to the tissue. However, our 
client, Zoe Reidinger informed us that minor necrosis at the very ends of the tissue sample was acceptable 
because this portion can be removed. Because the TEVGs must be cultured under incubator conditions, 
the dimensions of the bioreactor cannot exceed those of the incubator.  
To sterilize the device, the materials used needed to be disposable or able to be sterilized in some 
manner. Autoclaving was the chosen method for sterilization because it is the preferred method in the 
Rolle lab. This also eliminated any additional costs associated with other methods of sterilization.  
The design of the device was to cost $496 or less, since WPI was funding the project at $124 per team 
member. We selected materials carefully to ensure that the budget was not exceeded. Moreover, there 
were only twenty-eight weeks to design, build, and test a bioreactor to prove the concept of the design. 
We worked in a timely manner to complete the assigned tasks. This limited design period created a tight 
schedule for developing and selecting a design, manufacturing and testing the prototype, manufacturing 
and testing the final device, and constructing the final report.  
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3.4: Design Objectives 
  
Through our client meetings with Prof. Rolle and Zoe Reidinger and a review of the current literature, 
we were able to identify seven main objectives for the device. All objectives are shown in Table 1. 
 
Table 1: Objectives 
Objective 
Laminar Flow 
Prevent Leakage 
Isolated Flow Loop 
Remain Sterile 
Limit Mounting Time 
Easy to Machine 
Accommodate Different Samples 
Cost Effective 
 
 
Laminar flow provides a constant shear stress to the lumen of the TEVG. Laminar flow is necessary 
to simulate the in vivo environment of vascular tissue (Brooks, Lelkes, & Rubanyi, 2002). The constant 
shear stress prevents cellular occlusion of the graft (Wang et al., 2006). 
An isolated luminal flow loop was an objective of our design because it reduced the risk of cross-
contamination in the bioreactor. It would allow for an increase in the types of experiments that could be 
conducted on the TEVG because different media could be used internally and externally.  
In order to achieve accurate results from the experimental research conducted using the bioreactor, 
the device must be sterile and not leak. Leaking wastes cell culture media and can cause contamination. 
The loss of media increases the operational cost and can cause the sample to become dehydrated. The 
presence of pathogens, such as bacteria, could affect the development of the TEVG (Inaba et al., 2009). It 
is important to eliminate pathogen presence to ensure that histological results are due to the dynamic flow 
in the bioreactor. By eliminating leakage, we reduced the amount of media used and ensured sterility. The 
bioreactor needed to remain sterile during the duration of a culturing experiment in order to reduce risk of 
contamination. Contamination increases the presence of pathogens, which can damage the TEVG. 
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Streamlining the mounting process would increase the efficiency of the experiments using the 
bioreactor. This is because each sample is mounted outside of a media bath and the TEVG could 
dehydrate if exposed to the air for an extended period. With a shorter mounting process, the overall time 
needed to run an experiment would be reduced.  
In order to address ease of manufacturing, we created a simple design. Simplicity ensured that during 
manufacturing, we could prevent as many machining errors as possible. Due to the small scale of the 
TEVG and the subsequent small scale of the bioreactor, even small errors in machining could render the 
bioreactor unusable. In a further attempt to limit machining errors, we considered using commercially 
available parts as alternatives to machined parts. We believed that by reducing the amount of material and 
media used during manufacturing and operation, it would also reduce the overall cost of the device. 
Achievement of the manufacturing objective would reduce the chances of leakage and contamination due 
to manufacturing errors. 
The mounting mechanism should also be able to accommodate different sized samples. This would 
increase productivity and allow the bioreactor to accommodate samples of different dimensions along 
with the inherent variance amongst the samples themselves.  
Finally, we decided that ideally the bioreactor would cost less than or equal to the design currently 
being used to culture TEVGs. This would prevent an increase in experimental costs for Prof. Rolle’s 
laboratory and prevent any reduction in the number of TEVGs that could be cultured concurrently. 
We evaluated the objectives using a pairwise comparison chart, as shown in Appendix A. The ranked 
objectives are shown in Table 2. We ranked these objectives based on a literature review and personal 
communication with our client and users. 
 
Table 2: Ranked objectives (descending importance) 
1. Laminar Flow 
2. Prevent Leakage 
3. Remain Sterile 
4. Limit Mounting Time 
5. Isolated Flow Loop 
6. Easy to Machine 
7. Accommodate Different 
Sized  Samples 
8. Cost Effective 
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3.5: Functions and Specifications 
 
The functions of the bioreactor described the actions the bioreactor must perform on the specific 
TEVGs fabricated in the Rolle lab. The specifications were the metrics we had to achieve in order to 
achieve each function. The functions and specifications are summarized in Table 3. The four functions of 
the device were to provide laminar flow, apply shear stress to lumen, accommodate TEVGs cultured in 
Prof. Rolle’s laboratory, and fit in the laboratory incubator.  
 
Table 3: Functions and specifications 
Function Specification 
Provide laminar flow 
Reynolds number < 2100 
Entrance length 
Apply shear stress to lumen Shear stress = 10 dynes/cm
2 
Accommodate samples cultured in the Rolle 
laboratory 
12-14 day old rat aortic SMC-derived TEVGs 
10 mm in length and 1.2 mm in diameter 
Fit inside laboratory incubator 
Overall dimensions must be less than 
3 ft. by 3 ft. by 3 ft. 
 
From the client statement, we determined the required shear stress on the walls of the TEVG was 10 
dynes/cm
2
 (1 Pa) for a 10 mm long and 1.2 mm inner diameter tissue sample. We estimated the viscosity 
(µ) to be equal to that of water. Using these values, we calculated the desired average velocity using 
Equation 5. Since the bioreactor system could incorporate tubes of varying diameters, we calculated the 
desired flow rate of the entire system based on the specifications of the TEVG. The flow rate would be 
controlled by the pump. 
 
Equation 5: Velocity calculation from shear stress in TEVG, where τ is shear stress, µ is dynamic viscosity of the fluid, U is mean 
velocity of the fluid, and D is the inner diameter of the pipe 
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With a known velocity, we calculated Reynolds number in the tissue tube using Equation 6. Laminar 
flow is characterized by a Reynolds number less than 2100 (Waite & Fine, 2007). We estimated the 
media viscosity (µ) and density (ρ) to be equal to the values of water. 
 
Equation 6: Reynolds number calculation in TEVG, where ρ is the density of the fluid, U is the velocity of the fluid, μ is the 
dynamic viscosity of the fluid, and D is the inner diameter of the tube 
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After confirming that the flow would be laminar in the TEVG for the desired shear stress, we tested 
the settings on the Fischer Scientific Peristaltic Pump provided to us to determine which setting allowed a 
flow of 14.7 mL/min. An image of the pump is show in Figure 14. The control knob is located in the 
lower left corner of the pump and the slow/fast switch is located next to the power switch. We timed how 
long each setting took to fill a 10 mL graduated cylinder. We performed the test twice times for each 
pump setting. The data are shown in Table 4. 
 
 
Figure 14: Fischer Scientific Peristaltic Pump 
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Table 4: Pump flow rate test 
Setting Average Time to Fill 10 mL (s) Flow Rate (mL/min) 
Slow 0 14.5 4.2 ± 0.1 
Slow 2 91.0 6.6 ± 0.1 
Slow 4 63.5 9.4 ± 0.1 
Slow 6 46.5 12.9 ± 0.2 
Slow 8 38.5 15.6 ± 0.3 
Slow 10 35.5 16.9 ± 0.3 
Fast 0 58.5 10.3 ± 0.1 
Fast 2 45.5 13.2 ± 0.2 
Fast 4 39.5 15.2 ± 0.3 
Fast 6 34.5 17.4 ± 0.4 
Fast 8 29.5 20.3 ± 0.5 
Fast 10 28.5 21.1 ± 0.5 
  
Slow 8 provided a close flow rate to 14.7 mL/min, so we tested values between Slow 6 and Slow 8. 
After testing Slow 7, we determined the setting needed to be between Slow 7 and Slow 8. These values 
are shown in Table 5. Because the flow rate of Slow 7 ½ was 14.6 mL/min, we determined that was the 
most accurate setting for the TEVGs. 
 
Table 5: Pump flow rates between Slow 7 and Slow 8 
Setting Average Time to Fill 10 mL (s) Flow Rate (mL/min) 
Slow 7 43.5 13.8 ± 0.2 
Slow 7 ¼ 42.5 14.1 ± 0.2 
Slow 7 ½ 41.5 14.5 ± 0.2 
Slow 7 ¾ 38.5 15.6 ± 0.3 
 
3.6: Revised Client Statement 
 
After we finalized the objectives and constraints, we constructed this final client statement: 
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The goal of this project is to create a novel bioreactor system, which incorporates laminar luminal 
flow and a shear stress of 10 dynes/cm
2
 to generate appropriate mechanical conditioning for engineered 
vascular tissue samples. It should remain sterile and be able to culture samples that are 10 mm in length 
and have an inner diameter of 1.2 mm. In addition, the bioreactor must not leak, must not damage the 
tissue samples, and should include an efficient method of mounting the tissue samples. Ideally, the device 
should be easy to assemble and should create as few waste products as possible through its 
manufacturing and use. 
 
3.7: Project Approach 
 
The most important design criteria were providing laminar flow, preventing leakage, remaining 
sterile, and limiting mounting time. Using the design criteria and the literature review, we developed a 
series of design alternatives. We created preliminary prototypes of the alternative that best addressed the 
criteria. After several iterations of the initial prototype, the device evolved into the final design presented 
in this report. We developed experiments that addressed each of the design criteria to determine the 
success of the device. The results of the experimental testing were then used to make final 
recommendations to the design.  
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Chapter 4: Alternative Designs 
 
Considering the constraints, objectives, functions, and specifications presented in Chapter 3, we 
created a morphological chart that provided different means for each function, shown in Table 6. From 
this exercise, we were able to organize our design ideas and develop four different design alternatives. 
These four design alternatives were the plunger design, cross-flow design, jar design, and drawer design. 
 
Table 6: Morphological Chart 
Functions Means 
Secure 
the 
sample 
O-rings Sutures 
Inflatable 
cuff 
Glue 
Grow tissue on 
mount that attaches 
to bioreactor 
Clamps 
Permit 
gas 
exchange 
Permeable 
tubing 
Filter 
Direct 
contact 
Dissolved 
gas in 
media 
  
Mount 
the 
sample 
Needle 
Micropipette 
tips 
Barbed 
tip    
Contain 
sample 
Sample in 
lid 
Sample in 
reservoir 
Between 
plungers    
Supply 
media to 
exterior 
Static Dynamic 
    
 
4.1: Plunger Design 
 
The plunger design was modeled after a laboratory syringe and a SolidWorks drawing of the device is 
shown in Figure 15. The design used two hollow plungers, shown in blue. They were designed to slide 
independently of one another to adjust to the length of the TEVG, which would be mounted in the middle 
of the device, shown in red. After they were adjusted, the plungers would be fixed in place using support 
rods, shown in yellow. The length of the support rods would be modified to prevent the plungers from 
moving independently when inserting the sample. This addition would increase stability and prevent 
damage to the TEVG. In order to access and mount the sample, both plungers would need to be pushed 
out of the device through one side. The design used needles, in gray, attached to the ends of the plungers 
to mount the TEVG. The inlet and outlet ports of both the reservoir and the plungers would be connected 
to a pump using silicone tubing, which is not shown in the figure.  
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Figure 15: Isometric view of plunger design 
  
Anticipated problems with this design included leakage due to the number of connection points and 
the gaskets isolating the reservoir. If the gaskets were to fit snugly in the tube to prevent leakage, the seal 
may have been too tight to put the plungers inside the tube efficiently. For this reason, we foresaw a 
challenge in putting the plungers back in the tube with a delicate TEVG mounted inside. The distances 
between the plungers was not fixed, which could cause instability. The reservoir would need a support 
structure to keep it from rolling in the incubator or in the biosafety cabinet due to its cylindrical geometry. 
Because the flow in the reservoir is dynamic, we anticipated that the amount of tubing would hinder the 
assembly of the setup and the transportation from the biosafety cabinet to the incubator. 
 
4.2: Cross-Flow Design 
 
We believed the cross-flow design to be the simplest design alternative, shown in Figure 16. In this 
design, the TEVG was mounted between two blunted needles inside a rectangular reservoir. In addition to 
the interior flow loop, an external flow loop was created by the addition of an inlet and outlet port on the 
reservoir. A simple rectangular lid was also included in this design, but is not shown in the figure. 
Multiple TEVGs could be cultured in a single experiment by running the reservoir flow loops in parallel 
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rather than having excessive tubing, and the design could be modified to accommodate multiple TEVGs 
in one reservoir.  
 
 
Figure 16: Isometric view of cross-flow design 
  
We expected this design may have problems with leakage at the inlet and outlet ports of the external 
flow loop because they are below the media level. In addition, this design did not allow for the 
accommodation of different TEVG lengths; adjustment would require an entirely new device to be 
manufactured. The reservoir would require milling, a process used in the Cerulli et al. bioreactor that we 
deemed undesirable because more material is needed per bioreactor. Like the plunger design, the reservoir 
is dynamic. Consequently, we anticipated that the amount of tubing would hinder the assembly of the 
setup and the transportation from the biosafety cabinet to the incubator. 
 
4.3: Jar Design 
 
The jar design was the only design in which the TEVG was attached to the cap of the reservoir, 
shown in Figure 17. The TEVG would be then lowered into the media reservoir, which had its own 
separate flow loop. The cap also had space for an air filter, which allowed for gas exchange in the 
bioreactor reservoir. This design had the luminal inlet and outlet flow loops above the media level, which 
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we believed would reduce the chances of leakage at those points. By making use of the vertical space in 
the incubator, we expected that we could fit more bioreactors in the incubator at one time. 
 
 
Figure 17: Isometric view of jar design 
  
Similarly, this design had predicted limitations. Movement of the flexible tubing could impart 
undesired stresses on the TEVG and cause difficulty when mounting. These stresses in turn could cause 
inconsistent wall thicknesses or damage to the TEVG. Because the exterior flow loop connections are 
below the media level, the chances of leakage could be increased at those points. Like the previous two 
designs, we expected that the amount of tubing would interfere with the efficient assembly of the setup 
and transportation from the biosafety cabinet to the incubator because the exterior reservoir is dynamic. 
We expected that the TEVG would be difficult to mount in this bioreactor because there is no way to set 
the cap down steadily. 
 
4.4: Drawer Design 
 
The drawer design included a cartridge that can be removed from the device to aid in efficiently 
mounting the sample, as shown in Figure 18. It included isolated flow loops for luminal flow and exterior 
flow. The housing is shown in green in the figure and included four holes: two for interior flow and two 
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for exterior flow. The interior flow inlet and outlet are the closest to the top left, and the exterior inlet and 
outlet are labeled in the figure. The drawer in blue had inlets and outlets that corresponded to the green 
housing part. The TEVG would be mounted in the bioreactor on blunted needles attached to the drawer. A 
benefit of this design was that the bioreactor would be stable and the user could easily access the TEVG.  
 
 
Figure 18: Isometric view of drawer design 
 
This design alternative would require precise manufacturing to align the holes correctly. Because of 
the small diameter of the inlet and outlet ports, even a slight variation during manufacturing would cause 
misalignment. Manufacturing errors could cause the drawer to be too large for the housing or if the 
drawer were slightly too small, media would leak between the two parts. This design would require 
entirely new drawers to be designed and manufactured in order to accommodate different sized samples. 
Like the cross-flow design, manufacturing of this bioreactor would require milling, which we deemed 
undesirable as discussed previously. 
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4.5: Design Selection and Conceptual Final Design 
 
The conceptual final design was chosen based on our four main objectives, as discussed in section 
3.3. We used the sub-objectives as tools to evaluate the corresponding main objective during the design 
selection phase. However, some sub-objectives were omitted since the same method can be used in any 
design. For example, we ignored securing the sample because both O-rings and sutures could be used in 
any design. Further testing was required to determine which method would be most effective in our final 
design. Using the ranking of objectives and sub-objectives evaluated using the pairwise comparison charts 
in Appendix A, we rated each design conceptually in a selection-matrix, located in Appendix B. The jar 
design ranked the highest because of its ease of manufacturing. It could be made from commercial parts 
and has a simple geometry. We created and tested preliminary prototypes for multiple iterations of the jar 
design.  
 
4.6: Final Design Prototype 
 
After a discussion with our client, we confirmed that the jar design could meet the design criteria if 
we redesigned it to address its expected limitations. We decided to prototype a simplified jar design using 
Tupperware, straws, and a pasta tube as a TEVG model. This prototype can be seen in Figure 19.  
 
 
Figure 19: The prototype of the simplified jar design 
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After creating the first prototype, we decided to mount the TEVG vertically in the device to decrease 
its footprint in the incubator and the required volume of media. We also hypothesized that the 90º bends 
in the interior flow loop in the horizontal prototype could disturb the laminar flow of the media through 
the lumen of the TEVG. The vertical mount model was created out of a plastic container using straws to 
simulate tubing and pink cuffs to hold the straws in place. The first iteration of the vertical mount design 
is shown in Figure 20.  
 
 
Figure 20: An open view of the preliminary vertical mount design 
 
Because silicone tubing is flexible, the pink cuffs in the prototype evolved into a larger support piece. 
The piece was designed so that the tubing could be fed through the support piece as shown in Figure 21. 
We expected this would reduce leakage by providing a continuous flow loop. This vertical mount design 
was modeled in SolidWorks, shown in Figure 21. The original design used a BD Falcon Tube as a 
reservoir. We chose a BD Falcon Tube because it is a commercially available part that is readily 
obtainable in a laboratory setting. They are available in polypropylene, which can be sterilized in an 
autoclave. Test tube holders manufactured to the dimensions of a BD Falcon Tube can be purchased 
commercially. The material we selected for the support piece, depicted in purple in Figure 21, was 
polycarbonate because it does not deform in the autoclave, it is inexpensive for the size part we designed, 
and it can be manufactured in the WPI Machine Shop.  
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Figure 21: An isometric view of the first model of the vertical mount design 
 
After a conversation with the machinist at the WPI Machine Shop, we decided that several changes to 
the design could improve the manufacturability and functionality of the support piece. Luer connectors 
were added at either end of the polycarbonate support piece to decrease leakage and increase 
reproducibility. The Luer connectors are commercially available, sold by multiple vendors, can be 
sterilized in an autoclave, and can be replaced if damaged. Female Luer connectors to needle mounts 
come in a variety of different diameters and length, so they can be changed to house different sized 
samples. These needle mounts were available in the required entrance length to develop laminar flow. 
This calculation is discussed in Chapter 5. Additionally, the rounded faces were altered to be rectangular 
to reduce the time needed to machine the part. However, these changes resulted in a support piece that 
was too large to fit inside a BD Falcon Tube. To accommodate the new geometry of the design, we chose 
a glass 38 mm diameter by 200 mm long test tube. We also added a tapped hole where the support piece 
is attached to a size 8 silicone plug using a number 10-24 3-inch stainless steel screw. We selected a 
stainless steel screw to prevent rust from affecting the tissue sample. The SolidWorks image of this 
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design is exhibited in Figure 22. A description of how to assembly the bioreactor system is shown in 
Appendix D. 
 
 
Figure 22: The current iteration of the vertical mount design: SolidWorks design (L) and photograph (R) 
 
We selected parts for the device that would minimize overall cost and difficulty of machining. As 
seen in Figure 22 and the accompanying picture of the final prototype, all parts of the bioreactor are 
commercially available, excluding the support piece.  
 
4.6.1: Design Evolution 
 
The first iteration of the design suffered from errors in manufacturing. The drill bit used to create the 
vertical holes was not long enough to drill through the entirety of the support piece. The machinist needed 
to drill a hole from either side to pass completely through the support piece, which resulted in 
misalignment of the holes, and subsequently the needles. This misalignment of the needles was 
exacerbated by creating the threads for the Luer connectors manually.  
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During the second iteration of machining, we ordered a six-inch drill bit that could drill the hole in the 
support piece continuously. The support piece no longer needed to be rotated during manufacturing, and 
the hole was aligned. However, because the machinist created the threads manually, we still observed 
misalignment of the needles. When we performed a preliminary isolated luminal flow loop test, we 
observed leakage at the thread interface and added O-rings at these connection points. We performed 
preliminary TEVG mounting tests and found the TEVGs are generally 6 mm long after removal from the 
mandrel. These testing procedures are described in Chapter 5. The results of the preliminary TEVG 
mounting tests prompted two additional design changes. 
The expected length of the TEVGs when being mounted into the bioreactor was 10 mm. However, 
the TEVGs are approximately 6 mm long after being removed from the silicone mandrel. This 
discrepancy in the size of the TEVGs caused the gap between the two needle mounts to be too large. 
Additionally, because both the mounts were stationary it was more difficult to mount the TEVG using the 
user’s preferred method. The mounting procedure is described in Appendix C. In order to make the 
bioreactor easier to use, we decided to make one of the needle mounts adjustable. We also increased the 
length of the needle mounts. This was done to reduce the gap to 4 mm to accommodate the shorter 
TEVGs and to allow for a change in entrance length. Originally, the entrance length was calculated based 
on the Reynolds number of the TEVG. After personal communication with Prof. Brian Savilonis, we 
discovered the entrance length should be calculated based on the Reynolds number in the needle 
(2/15/2013). The new entrance length was 27 mm. The calculation is discussed further in Chapter 5. 
The adjustable mount was made by creating a milled pocket in the polycarbonate support piece. The 
adjustable mount was machined as a separate component that could be inserted into the milled pocket and 
slid back and forth as needed. A stainless steel pin was used to fix the adjustable mount in place by 
inserting the pin through a hole in both the polycarbonate support piece and adjustable mount. Figure 23 
shows the adjustable design with the adjustable mount locked in place and Figure 24 shows the adjustable 
mount isolated.  
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Figure 23: Adjustable bioreactor design 
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Figure 24: Adjustable mount, isometric view (left) and front view (right) 
 
With these changes, our final design was complete. We began the process of validating the final 
design through a set of experiments. The experiments evaluated the success of bioreactor based on the 
project goals and criteria.   
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Chapter 5: Experimental Testing 
 
In order to test how well our bioreactor addressed the project objectives, constraints, and functions, 
we experimentally evaluated the bioreactor. The testing methods and materials that were used are 
discussed in this chapter. These procedures were developed using a thorough literature review and 
discussions with our client. Of the design criteria discussed in Chapter 4, we tested and, when appropriate, 
statistically analyzed laminar luminal flow, isolated luminal flow loop, leakage, mounting of the tissue 
sample, sterility maintenance, gas exchange, and the effect of the bioreactor on the TEVG. We discuss the 
results of this experimentation in Chapter 6.  
Assembling the bioreactor was a prerequisite for many of the experiments described in this section. A 
brief overview of how to assemble the bioreactor is presented here to assist in understanding the 
following experiments. To begin the assembly process, all components of the bioreactor need to be 
sterilized using an autoclave. All components should then be transported to the biosafety cabinet and 
assembled, after which the TEVG should be mounted into the bioreactor. The luminal flow loop should 
then be primed inside the biosafety cabinet, as discussed in Appendix E. The bioreactor should then be 
transported to the incubator with the pump placed on top. A detailed protocol for assembly is provided in 
Appendix D. 
 
5.1: Laminar Flow 
 
We tested for laminar flow using a dye test. We set up the bioreactor using the directions found in 
Appendix D, using a 10 mm long and 1.2 mm inner diameter silicone tube as the TEVG. The pump was 
set to Slow 7.5, correlating to 14.7 mL/min. A syringe filled with food dye was injected upstream of the 
silicone tube 40 mm before the inlet barb connector. The location was chosen so that the dye bolus would 
be upstream of the needle to allow laminar flow to develop. The reservoir was not attached in order to see 
the bolus more clearly. We determined that laminar flow would be present if the flow profile was 
parabolic with no eddies.  
No flow pattern indicative of either laminar or turbulent flow was observed because the dye mixed 
with the water due to turbulence from passing through the multiple Luer connectors. Mixing also occurred 
from passing thorough the changing radii from needle hub to needle. This test was inconclusive since it 
did not show any separation of layers as seen in laminar flow, nor did it show the characteristic eddies 
seen in turbulent flow.  
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As a result, we attempted the bolus test again using olive oil instead of water using the same method 
as the dye test. We hypothesized that the olive oil would not mix with the water since it is more viscous 
than the dye. The oil was immiscible in the water, which caused the oil to fracture into smaller spheres as 
the oil entered the silicone tubing. The oil was also difficult to inject using the syringe because of its high 
viscosity, which resulted in a poor initial bolus. Moreover, the oil is less dense than the water used in the 
flow loop, consequently the oil rose to the top of the flow loop instead of flowing with the water.  
Laminar flow was also evaluated empirically using the Reynolds number calculation. The calculated 
Reynolds number was 376. This calculation can be found in section 3.4 under specifications and is 
repeated here in Equation 7.  
 
Equation 7: Reynolds number in TEVG, ρ is the density of the fluid, U is the velocity of the fluid, μ is the dynamic viscosity 
of the fluid, and D is the inner diameter of the tube. 
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Additionally, we also met with Professor Brian Savilonis, a Mechanical Engineering professor at WPI 
who specialized in fluid dynamics. Professor Savilonis also agreed that the bioreactor would provide 
laminar flow to the tissue sample in the bioreactor as long as the needles were long enough for laminar 
flow to develop. To achieve laminar flow, we needed to calculate the entrance length based on the 
Reynolds number and the velocity in the needle, which is different from the Reynolds number in the 
TEVG due to a difference in diameter. This calculation is shown in Equation 8. 
 
Equation 8: Velocity of the fluid in 18 gauge needle, where UT is the velocity of fluid in the TEVG, AT is the cross sectional 
area of the TEVG, UN is the velocity of fluid in the needle, and AN is the cross sectional area of the needle  
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Using this velocity, we calculated the Reynolds number in the needle, illustrated in Equation 9, and 
the entrance length required to develop laminar flow in the needle, shown in Equation 10. 
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Equation 9: Reynolds number in 18-gauge needle, where ReN is the Reynolds number in the needle,   is the density of the fluid, 
UN is the velocity of the fluid in the needle, DN is the inner diameter of the needle, and    is the dynamic viscosity of the fluid 
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Equation 10: Entrance length of needle, where Le is the entrance length, ReN is the Reynolds number in the needle, and DN is the 
inner diameter of the needle 
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5.2: Isolated Flow Loop 
 
To test if the luminal flow loop was isolated from the reservoir, we used a dye test. We assembled the 
bioreactor and filled the reservoir with clear deionized (DI) water. We then filled the internal flow loop 
with 0.01 mL red food dye per 1 mL of DI water. We ran the bioreactor for one hour, at which point we 
checked for the presence of red dye in the reservoir. We observed leakage into the reservoir and 
subsequently placed silicone O-rings at the thread interface, shown in Figure 25. We ran the bioreactor for 
one hour after implementing the O-rings and observed no visible leakage in the reservoir. To confirm this, 
we used a spectrophotometer to measure absorbance values.  
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Figure 25: Leakage observed at the thread interface (left) and thread interface with O-rings (right) 
 
Using a Jenway 6305 UV/Vis Spectrophotometer set to 530 nm, a standard curve of absorbance 
values was created using five samples with increasing concentration of dye. Clear DI water was used as 
the control. A graph of the standard curve is shown in Figure 26. The standard curve and the absorbance 
values of the experimental sample were used to determine the presence of food dye in the reservoir. The 
absorbance value of the water in the reservoir after one hour was 0.06. Using a student’s t-test, we 
statistically compared the absorbance values of the experimental sample and the DI water control and the 
p-value was 0.08 and n=3. We found that the spectrophotometer used could only detect a difference in the 
absorbance values between the DI water control and greater than 0.002 mL dye per mL water.  
 
 
Figure 26: Standard curve of absorbance values: the grey area denotes statistically insignificant readings and the red line shows 
experimental value 
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We also used a white cloth to wipe the connectors, tubing, and lid of the bioreactor to test for the 
presence of red dyed DI water outside the reservoir. Red dyed DI water did not appear on the cloth. 
 
5.3: Mounting Time  
 
In this test, we measured the average amount of time it took to mount a silicone tube onto the needle 
mounts in our bioreactor. We chose to use a silicone tube instead of tissue in order to conserve tissue 
samples, as shown in Figure 27. This test was conducted by following the same sterile procedure we 
would use to mount tissue into the device, described in Appendix C.  
 
 
Figure 27: A view of the polycarbonate support piece and a mounted and sutured silicone tube, circled in red 
 
Zoe Reidinger performed the mounting procedure because she is the primary user and she used a 
silicone tube in order to conserve TEVGs. We timed three mounting trials in the biosafety cabinet 
following the procedure we developed for live TEVGs, detailed in Appendix C, using both the Cerulli et 
al. bioreactor design and our design. The collected data are shown in Table 7 and Figure 28; the Cerulli et 
al. bioreactor design took 158 ± 7 seconds to mount and our device took 133 ± 21 seconds to mount. 
 
Table 7: Mounting time data 
Trial 
Cerulli et 
al. 
Bioreactor 
Our 
Bioreactor 
1 162 122 
2 150 157 
3 162 119 
Average 158 133 
Standard 
Deviation (±) 
7 21 
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Figure 28: Mounting time  
 
5.4: Sterility During Operation 
 
In order to ensure that the bioreactor remains completely sterile during operation, we developed an 
experimental plan using microscope observations and clarity of media to evaluate microbial growth in the 
bioreactor. The bioreactor and other essential components were first sterilized using an autoclave for 15 
minutes at 121⁰C and at 2 atm, while inside an autoclave bag. Afterward, the bioreactor was placed on a 
piece of sterilized aluminum foil within the biosafety cabinet to maintain a sterile working space. All the 
components used in the experiment can be found in Table 8. The necessary tubing connections were 
assembled and cell culture media was added to the reservoir. Then the tubing was primed using the 
protocol in Appendix E. The bioreactor was then placed into the incubator. A tissue culture polystyrene 
petri dish was filled with media and placed in the incubator to serve as a control. The incubator setup can 
be seen in Figure 29. 
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Table 8: List of bioreactor components used in the sterility experiment 
Silicone Tubing: Connectors: Silicone Stopper: Miscellaneous: 
Inlet section 2x Thread to barb 1x Silicone stopper 1x sheet of tinfoil 
Outlet section 
2x Female Luer to 
thread 
1x 3in Stainless steel screw 1x 38 by 200mm test tube 
Priming section 2x blunt ended needle  4x silicone O-rings 
 
 
Figure 29: Sterility test setup 
 
The sterility experiment was terminated prematurely when leakage was observed at the interface 
between the pump and silicone tubing causing the luminal flow loop to fill with air. The plastic bin 
containing the pump, which was located on top of the incubator, was filled with several milliliters of 
media, shown in Figure 30. Dried media was also present on the pump itself. Upon visual inspection, 
media in the bioreactor reservoir did not appear turbid indicating no contamination. 
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Figure 30: Leakage from sterility test 
 
This test was repeated and we followed the same procedure that was discussed previously. In this test, 
all connection points remained tight and no leakage was observed. The media remained clear and not 
turbid throughout the four days of running the bioreactor in the incubator. We also concluded that there 
was no contamination in the system by observing media samples of the control petri dish as well as the 
bioreactor’s reservoir under the microscope. No organisms were observed in the media and the media was 
not turbid in either sample, shown in Figure 31.  
 
 
Figure 31: Media after four days in incubator, control (left) and bioreactor sample (right) 
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5.5: Tissue Culture 
 
We attempted to mount TEVGs into the bioreactor on multiple occasions. The first time we attempted 
this test, the gap between the needles in the bioreactor was too large, and the device did not allow any 
adjustability. The TEVGs that were cultured for the second and third trials could not be mounted in the 
bioreactor because they were contaminated during static culture. The final time we attempted to mount 
TEVGs into the bioreactor, only two could be successfully mounted and neither stayed securely mounted 
throughout the experiment. 
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Chapter 6: Discussion and Conclusions 
 
After performing the experiments discussed previously, we adjusted our final bioreactor design to 
remedy any limitations discovered. Our final design is composed of several major components; a 
polycarbonate support piece, a fixed mounting arm, an adjustable mounting arm, a glass test tube that 
serves as a reservoir, and a silicone stopper. The adjustable mounting arm can be slid along a milled 
pocket of the polycarbonate support piece and then fixed in place using a stainless steel pin. This arm 
reduces the mounting time because the needle mounts can be moved together while they are being 
sutured, providing support to the TEVG. Once mounted in the bioreactor, the TEVG is oriented vertically 
within the test tube. 
The polycarbonate support piece is attached to the silicone stopper using a stainless steel screw to 
ensure that the system remains stationary and self-contained during operation. The seal between the 
stopper and the test tube prevents leakage and contamination. Both mounting arms are composed of an 18 
gauge blunt needle, a female Luer-to-thread connector, and a thread-to-barb connector. This allows 
platinum-cured silicone tubing to be connected to each mounting arm and the TEVG to be mounted 
between them, forming an isolated luminal flow loop. This silicone tubing is threaded through two holes 
in the silicone stopper and then attached to a peristaltic pump. All materials chosen could be sterilized in 
an autoclave, which is the preferred method of sterilization in the laboratory. We also chose to incorporate 
commercial parts to increase reproducibility and allow the bioreactor to accommodate TEVGs of different 
sizes. The rectangular geometry of the polycarbonate support piece allowed the bioreactor to be easily 
machined. 
Based on the testing results presented in Chapter 5, we were able to evaluate the bioreactor’s 
performance of the objectives introduced in Chapter 3. The following sections discuss the results of the 
laminar flow testing, the isolated flow loop and leakage testing, the mounting efficiency of the device, 
and the sterility experiment. We also discuss the qualitative assessment of the bioreactor’s tissue culture 
trials, ease of manufacturing, ability to accommodate different sized samples, ability to permit gas 
exchange, and material cost. We discuss the limitations of our testing and the relationship between the 
device and the following topics: economics, environmental impact, societal influence, political 
ramifications, ethical concern, health and safety issues, manufacturability, and sustainability. 
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6.1: Laminar Flow Testing 
 
Due to the lack of results in the bolus test with both the dye and oil, we deemed both of these tests 
inconclusive. However, laminar flow through the tissue tube is still strongly supported by calculations, as 
discussed in section 3.4. The Reynolds number was 376 in the TEVG and 539 in the needle, indicating 
laminar flow. The inlet needle length allowed for fully developed laminar flow. The limitations of this 
analysis were that the Reynolds number calculation is for fluid moving through a rigid tube and the 
TEVG is compliant. However, published literature regarding biofluid mechanics uses rigid tubes as an 
approximation for vascular tissue (Waite & Fine, 2007). Another limitation of the laminar flow testing 
was that the graft was slightly larger in diameter than the needle mount. This would require laminar flow 
to fully develop again after passing through the needle into the TEVG. However, the discrepancy in the 
diameters was necessary because the needle had to fit inside the TEVG to be mounted into the bioreactor. 
 
6.2: Isolated Flow Loop and Leakage Testing 
 
The average absorbance value of the water in reservoir was 0.06±0.01. Since this is lower than the 
resolution of the spectrophotometer, 0.07±0.003, we concluded that there was no statistically significant 
leakage into the reservoir (p=0.083, n=5). Because of this analysis and the absence of red dyed water on 
the cloth, we concluded that our bioreactor did not leak. This test is limited because we only ran the 
bioreactor system for one hour and therefore the data do not account for leakage over a longer period.  
 
6.3: Mounting Efficiency 
 
Because there was no statistically significant difference between the Cerulli et al. bioreactor and our 
device, we concluded that our design did not increase the mounting time. Because the time needed to 
mount a TEVG on the Cerulli et al. bioreactor did not dehydrate the TEVG and lead to necrosis, we 
determined that TEVGs would not dehydrate during the mounting process into our bioreactor. A 
limitation of this test was that Zoe had over six months of mounting experience on the Cerulli et al. 
bioreactor. Additionally, the needles did not align perfectly in our design. This could cause an increase in 
mounting time. The needle misalignment and its effect on the functionality of our design are addressed 
further in Chapter 7. 
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6.4: Maintaining Sterility  
 
We determined the device could maintain sterile over a four-day period because the media samples 
did not become turbid and we observed no evidence of microbial growth using the microscope. 
 
6.5: Tissue Culture 
 
During the tissue culture trials, we reiterated our original prototype into the final design presented in 
Chapter 4. The first tissue culture trial resulted in the development of the mobile arm. Because the 
original design was stationary, it was very difficult for the user to mount the TEVG into the bioreactor. 
We were also able to finalize the protocols for mounting, assembly, and priming, which can be found in 
Appendices C, D, and E, respectively. The next two attempts of tissue culture trials were prevented 
because of contamination of the grafts while they were being cultured statically. The final tissue culture 
period was successful, and the TEVGs were mounted in the bioreactor. Of the seven TEVGs that were 
cultured, only two were mounted successfully in the bioreactor. This was due to the delicate nature of the 
grafts and the fact they were harvested at day fourteen, the earliest they could be harvested. The first graft 
mounted on the bioreactor fell off the inlet needle when the pump was turned on. Upon investigating an 
image of the TEVG on the bioreactor before media was flowed through it, we found that it was not 
properly sutured on this end. The second TEVG mounted in the bioreactor suffered the same fate: it was 
dislodged from the needle mounts when the pump was turned on. We attributed this failure to the 
challenges of mounting a delicate graft. Unfortunately, we ran out of time to culture the TEVGs and could 
not attempt any further tissue trials. 
We believe that with more TEVG samples, we could successfully mount a sample into the bioreactor. 
This is because the Cerulli et al. bioreactor was able to accommodate TEVGs for the entire duration of an 
experiment and it incorporated identical needles and a similar suturing process. The lack of histological 
tissue culture data is the greatest limitation of this project: we were unable to determine definitively the 
effect of our bioreactor on the TEVGs cultured in the Rolle laboratory. However, we have developed an 
in depth experimental plan for the tissue culture process, which is discussed further in Chapter 7 and 
Appendix F. 
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6.6: Ease of Manufacturing 
 
Our device was easy to manufacture because there are only two parts that need to be machined at the 
WPI Machine Shop. Both of the parts, the main polycarbonate support piece as well as the movable 
mount, have a simple geometry that takes less than three hours to machine. All other parts of the 
bioreactor are commercially available. Using commercial parts allows damaged parts to be replaced 
easily, increases the reproducibility of the bioreactor, and decreases the time and costs associated with 
custom made parts. 
 
6.7: Various Sized Sample Accommodation 
 
The bioreactor was able to accommodate different sized samples by incorporating interchangeable 
needle hubs and the ability to machine different sized polycarbonate support pieces. The outlet needle can 
be cut to varying lengths to accommodate variations in tissue length. However, the inlet needle cannot be 
cut shorter than 27 mm to allow laminar flow to fully develop.  
 
6.8: Gas Exchange 
 
Past research shows that the surface area of 3 meters of gas-permeable silicone tubing in the isolated 
flow loop will allow sufficient gas exchange (Radisic et al., 2006). Our bioreactor design incorporates this 
necessary length. 
 
6.9: Cost Analysis 
 
Using one stopper, one test tube, two thread-barb Luer connectors, two thread-male Luer connectors, 
two needle hub-needle connectors, four O-rings and the necessary polycarbonate, a single bioreactor 
assembly costs $18.18. This tabulated cost can be seen in Appendix. This is less than the estimated cost of 
the previous bioreactor of $23.56. Our bioreactor also creates much less polycarbonate waste as it 
requires a very small amount of milling as compared to the large milled reservoir and lid of the previous 
bioreactor. This cost can be further reduced by buying parts in bulk, or by selecting a different 
stopper. This cost does not reflect the tubing costs of either bioreactor as both bioreactor assemblies 
should use roughly the same amount of tubing. 
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6.10: Impact of Device  
  
The overall purpose of the following sections is to discuss the implications of manufacturing this 
bioreactor design to the following areas: economics, the environment, society, politics, ethics, health and 
safety, manufacturing, and sustainable production. 
 
6.10.1: Economics 
 
Our bioreactor for TEVGs is the next step towards having an off-the-shelf vascular graft for use in 
medical procedures, which may reduce the time associated with finding a donor graft for use in surgeries. 
Compared to autologous grafts, the patient would only need to undergo one surgery; therefore, a TEVG 
would save him or her the cost of the secondary surgery. Our bioreactor is easy to manufacture, with few 
waste products and minimal labor. The use of this device will decrease the culturing time because grafts 
will achieve necessary mechanical strength in a shorter period. This will save these patients time and 
money. The device is also inexpensive to machine and produce, having a final build cost of $18.18 per 
bioreactor. The main cost of the device derives from the cell culture media required by the bioreactor to 
properly culture the TEVG. The bioreactor is a feasible method for growing three-dimensional constructs 
in the future.  
 
6.10.2: Environmental Impact 
 
Few waste products are generated in the manufacturing of our bioreactor because commercial parts 
are used and the device can be re-used multiple times. The only electricity required to run the bioreactor 
is for the pump, which could easily be solar powered in the future to decrease its environmental impact. 
This device does not produce any toxic chemicals that can negatively affect the environment. 
Polycarbonate is thermoplastic and can be recycled indefinitely (Müller & Rises, 1992). 
 
6.10.3: Societal Influence 
 
Our bioreactor, as well as tissue engineering in general, may one day play a role in improving the 
quality of life and extending the lifespan of countless people around the world. As tissue engineering 
becomes more advanced and standardized, tissue engineered organs and organ systems may one day 
become available to the general populace. Although the bioreactor is scaled for use in simulating the in 
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vivo environment of a rat carotid artery, it could be scaled up for use in human-sized veins and arteries in 
the future.  
 
6.10.4: Political Ramifications 
 
Because of controversy regarding the ethical use of cells and cell-derived product, the government 
regulates the use of these products. As a result, this could limit the progression of tissue engineering and 
eliminate the need for a bioreactor. 
 
6.10.5: Ethical Concern 
 
The use of cells and all cell-derived products used in our device may anger groups such as People for 
the Ethical Treatment of Animals (PETA) because animals can be harmed in the creation of the tissue. In 
the future, our bioreactor may aid in increasing the quality of life and lifespan of patients in need or a 
surgery involving a vascular graft. In addition, the patient will not need a second surgery to retrieve this 
type of graft or need a donor, and the needed graft can be pulled off the shelf or cultured using the 
patient’s own tissue.  
 
6.10.6: Health and Safety Issues  
 
This bioreactor is safe for the users of the device. No harmful chemical byproducts are produced from 
the device. Standard procedures for working with blood-borne pathogens should be followed when using 
any biological tissue in the device. Currently, the TEVGs produced using our bioreactor are not suitable 
for implantation and therefore are not a major health or safety concern at this time. If the TEVGs were to 
be implanted then it would need to follow all the regulations set by the FDA so that it does not harm the 
patient. Because the bioreactor is designed to prevent leakage, it is safe for the user. 
 
6.10.7: Manufacturability  
 
Our bioreactor can be reproduced easily. The only part that needs to be machined is the support piece 
that holds the tubes in place. Due to its simple geometry, it is easy to manufacture. The machining shop at 
WPI completed this in less than a week. The other parts of our design are commercially available and just 
need to be adjusted slightly to fit together.  
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6.10.8: Sustainability  
 
Our device is made of polycarbonate and polypropylene, which can be autoclaved. Since these 
materials can be autoclaved, the device can be used many times. It requires very little electricity to run as 
only the pump uses energy, and there are few non-biodegradable waste products.  
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Chapter 7: Conclusions and Future Recommendations 
 
To create a luminal laminar bioreactor that aided in maturing TEVGs, we developed design criteria 
with information gathered through a literature review and client meetings. We organized our criteria into 
constraints and objectives. The constraints narrowed our design space and stated what our device must 
accomplish. The constraints of the design were that is provide luminal flow, securely mount the tissue 
sample, permit gas exchange, fit inside incubator, be sterilizable, be within a $496 budget, and be 
completed within the 28-week time frame. The objectives are defined has characteristics our clients want 
our device to accomplish. The objectives include providing laminar flow, preventing leakage, an isolated 
flow loop, remaining sterile, limiting mounting time, easy to machine, accommodating different samples, 
and cost effective. The device that we created effectively met the design criteria that we established at the 
start of the project, and we believe that this Major Qualifying Project was a success. In this chapter, we 
discuss the major successes and shortcomings of this bioreactor and suggest future redesigns.  
 
7.1: Comparison to Cerulli et al. Bioreactor and Recommendations for Future 
Designs  
 
We produced a bioreactor that is functional and significant to the academic research that is conducted 
at WPI. Experiments with the TEVGs cultured in Professor Marsha Rolle’s laboratory can be performed 
in a controllable in vitro environment. Currently, the Rolle laboratory uses the Cerulli et al. bioreactor, 
described in Chapter 2. Although this bioreactor provides luminal flow, it cannot ensure laminar flow. 
The Cerulli et al. bioreactor may not have been exposing the tissue samples to the correct amount of 
shear stress. The needle lengths were too short to account for the entrance length needed to develop 
laminar flow, and in turn, a constant shear stress on the wall of the tissue engineered vascular graft. Our 
bioreactor accounts for this entrance length, ensuring that the desired shear stress is applied to the lumen 
of the TEVG. Although these needles are now the correct length for the development of laminar flow, any 
error in manufacturing of the threads designed to hold the Luer lock pipe adapters creates a noticeable 
error at the meeting point between the two needles due to the small scale of the bioreactor system. To 
remedy this, we suggest that the next iteration of the device is created using an automated system to 
prevent misalignment due to human error. 
Our bioreactor will not allow leakage at any point outside of the test tube reservoir as our design 
contains all connection points within the reservoir. The Cerulli et al. bioreactor design allows for leakage 
out of the reservoir, while our design eliminates all possible leakage into an incubator environment.  
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The Cerulli et al. bioreactor can accommodate TEVGs of varying lengths by sliding the adjustable 
arm back and forth along the magnetic track. This allows many different length samples to be mounted in 
the bioreactor. Although our design does involve an adjustable mount, it is only designed to accommodate 
one length sample. This can be somewhat overcome by using different length needle; however it does not 
allow the same degree of adjustability as the Cerulli et al. bioreactor. We propose a reiteration of our final 
design involving multiple holes for adjustment. This design is shown in Figure 32. This would allow a 
larger variety of TEVGs to be used in our bioreactor, but would not allow for as much instability as the 
magnetic mobile arm used in the Cerulli et al. design. 
 
 
Figure 32: A close-up view of the adjustable design with additional holes to allow for more adjustment, created in SolidWorks. 
  
In the Cerulli et al. device, the movable arm could be moved side to side, which could result in 
damage to the tissue sample or an interruption of laminar flow. Our device manages to be adjusted along 
only one axis with no possibility of rotation. Because the movable arm in our design must slide inside a 
milled pocket, the connection between this arm and the rest of the polycarbonate is loose. This could 
cause damage to the sample. Further testing is needed, but the team has redesigned the movable mount in 
order to make it more stable. Figure 33 illustrates this new design. The square shape of the main 
polycarbonate support piece fits within the square hole of the movable mount. This will allow the mount 
to move in only one direction with no possibility of tipping or rotating. This will create a more stable 
environment for the TEVG and remove the risk of breaking the TEVG while adjusting the movable 
mount.  
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Figure 33 A SolidWorks model of the stable adjustable design: assembly (L) isometric view of movable mount (TR) top view of 
movable mount (BR) 
 
A major drawback of our device is the silicone stopper. We ordered a four-gauge piercing needle to 
create holes in the stopper for the inlet and outlet tubing as well as the stainless steel screw. Not only is 
this process not reproducible, but it is time consuming and difficult. In the future, a polycarbonate cap that 
rests on the mouth of the test tube reservoir would be an improvement over our silicone stopper solution. 
A possible design for this cap is shown in Figure 34.  
 
 
Figure 34: A possible design of the polycarbonate cap 
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Currently, our bioreactor requires nearly 100 mL of complete media for one tissue sample. We 
suggest that the device be scaled down in order to fit in a smaller container and still provide luminal, 
laminar flow to a TEVG. This would decrease the running cost of the bioreactor and concurrently allow 
improved transportation from the biosafety cabinet to the incubator.  
We recommend that the Rolle laboratory use our bioreactor instead of the Cerulli et al. bioreactor for 
their continuing research involving TEVGs. The bioreactor should be tested further using 
recommendations presented in this chapter. After making the proposed changes to the design, we believe 
it would completely fulfill the requirements of the Rolle laboratory.  
 
7.2: Recommendations for Future Testing 
 
We recommend the following tissue culture experiments to determine the effect of the bioreactor on 
TEVGs. The TEVGs should be cultured statically using the direct cell seeding method and harvested at 
14-18 days. Two samples should be fixed immediately as the control, two samples should be mounted in 
the bioreactor without flow, and two samples should be mounted in the bioreactors with flow. The 
protocols for mounting the samples in the bioreactor and priming the pump are found in Protocol and 
Appendix E, respectively. The samples should be removed and fixed after 48 hours. One sample from 
each test group should be embedded in paraffin vertically in order to obtain luminal cross-sections, and 
one sample from each test group should be embedded in paraffin in such a way to observe the luminal cell 
alignment. H&E staining can be used to observe changes in the luminal diameter and cell alignment in the 
direction of media flow. Smooth muscle α-actin staining can be used to assess expression of actin in the 
lumen of the TEVG. Smooth muscle α-actin is an indicator of SMC behavior. We hypothesize we would 
see no change in the luminal diameter between the control sample and the sample cultured in the 
bioreactor under dynamic flow conditions (Fitzgerald et al., 2009). We expect to see increased cell 
alignment to the direction of flow on the lumen of the TEVGs cultured in the bioreactor when compared 
to the control and statically cultured samples (Fitzgerald et al., 2009). Finally, we anticipate a decrease in 
smooth muscle α-actin in the cells that were exposed to flow as they take on a more EC-like phenotype 
than SMC-like phenotype (Wang et al., 2006). The procedures for all tissue culture experimentation and 
preparation are found in Appendix F. 
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7.3: Conclusion 
 
A luminal laminar flow bioreactor is an important aspect of the tissue engineering process of vascular 
grafts. Because TEVGs have the potential to be vasoactive, non-immunogenic, customizable, and have an 
off-the-shelf availability, they could be a better option for many patients undergoing CABG surgery and 
dialysis. However, because the current technology is limited by the culturing period and inconsistency 
with native tissue, a bioreactor is necessary. In this report, we determined our design criteria, developed 
design alternatives, then manufactured and validated our final design. Our bioreactor design successfully 
incorporated an isolated luminal flow loop, remained sterile, provided laminar flow, was easy to machine, 
and could incorporate different sized samples. In the future, we recommend the mobile arm to be 
redesigned in order to increase needle mount stability and decrease mounting time. Moreover, the silicone 
cap should be replaced with a more reproducible and cost effective polycarbonate cap. To determine the 
effect of our bioreactor on TEVGs, we developed a tissue culture protocol to assist in future testing. After 
making the proposed changes to the design and conducting further experiments, we believe it would 
completely fulfill the needs of the TEVGs cultured in the Rolle laboratory.  
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Appendix A 
 
 
Isolated 
flow 
loop 
Remain 
sterile 
Limit 
mounting 
time 
Easy to 
machine 
Laminar 
flow 
Accommodate 
different sized 
samples 
Cost 
Efficient 
Prevent 
Leakage 
Isolated flow loop X 1 1 0 1 0 0 1 
Remain sterile 0 X 0 0 1 0 0 1 
Limit mounting 0 1 X 0 1 0 0 1 
Easy to machine 1 1 1 X 1 0 0 1 
Laminar flow 0 0 0 0 X 0 0 0 
Accommodate 
different sized 
samples 
1 1 1 1 1 X 0 1 
Cost efficient 1 1 1 1 1 1 X 1 
Prevent leakage 0 0 0 0 1 0 0 X 
Total 3 5 4 2 7 1 0 6 
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Appendix C 
 
 
 
1. Gather the sterile sutures, sterile tissue tube 
(silicone tube for clarity), stainless steel pin, and 
the polycarbonate support piece assembly 
 
 
2. The adjustable polycarbonate arm is easily 
removed from the main support piece 
 
3. The adjustable arm is removed in order to 
facilitate mounting 
 
4. The tube is slid onto the longer, static needle 
mount and the adjustable arm is reinserted into 
the milled pocket 
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5. The adjustable arm is slid in the milled pocket 
to aid the needles in meeting 
 
 
6. The tube is then slid so it rests on both needles 
 
7. The tube can be sutured to one needle 
 
8. The tube can then be sutured completely 
 
 
9. The stainless steel pin is reinserted for stability 
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Appendix D 
Note: This protocol was created with the non-adjustable iteration. However, when using the adjustable 
iteration, insert the pin into support piece before beginning in order to use this protocol.  
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Appendix E 
Isolated Flow Loop Priming Protocol 
 
Materials 
 Assembled pump with TEVG mounted (Steps 1 and 2) 
 20mL of larger sterile container for priming media 
 Rubber stopper with two holes for tubing 
 8 to 10 inches of tubing for the priming section  
 2 sterile clamps for the silicone tubing 
 Pump  
 Pump tube segments with two barb to barb connectors attached  
 
Procedure 
This procedure must be performed after the reservoir has been filled with 95 mL of media and the 
TEVG has been mounted.  
1. Assemble bioreactor as shown in Appendix D- Bioreactor assembly. 
2. Mount TEVG. 
3. Insert assembled bioreactor with TEVG into glass test tube with media. Set aside.  
4. Dispense 15mL of premade media into a sterile container.  
5. Feed inlet and outlet tubes attached to the bioreactor through a two holed rubber stopper. 
6. Insert the inlet port to the bioreactor into the sterile container with media. 
7. Attach the outlet port of the bioreactor to the inlet port of the pump 
8. Attach a priming segment to the outlet of the pump with the other end free on top of a sterile 
surface.  
9. Set the pump to “Forward” and the speed setting to “Prime/Purge” 
10. Allow media to fill all sections of tubing until half of the priming section if full. 
11. Turn of pump. 
12. Place clamps near the ends of the inlet and outlet tubes of the bioreactor. 
13. Detach the priming segment. 
14. Attach the bioreactor inlet segment to the pump outlet and remove clamps. You should now have 
a closed loop system with no air bubbles.  
15. Remove the pump segment with two barb-to-barb connectors from the pump keeping all 
connection points intact. 
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16. Place the pump on top of the incubator 
17. Feed the tubing and stopper through the hole at the back of the incubator 
18. Place pump segment back peristaltic pump.  
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Appendix F 
Tissue Culture Experimental Protocol 
 Gas exchange 
o What testing results and statistical analyses mean to the bioreactor  
o Which design criteria it addresses 
o How well this aspect of the device meets the criteria 
Before using the bioreactor for any tissue culture, it needs to be sterilized through autoclave the day 
before the experiment. Steps on how to sterilize the bioreactor are in the section below. 
 
Part 1. Sterilization  
 
Materials: For one bioreactor and one static control  
 Autoclave bag at least 7” by 12”, or enough aluminum foil to completely wrap all the materials  
 Every piece of the bioreactor  
o Support piece 
o 2 thread to barb connectors 
o 2 male Luer to thread connectors 
o 4 female Luer to needle mounts 
 2 for bioreactor 
 2 for static control 
o 4 silicone O-rings 
o Silicone stopper 
o Stainless steel screw 
o 2 test tubes 
o Silicone tubing- 10 ft. 
o Silicone tubing- length needed to reach pump through bioreactor 
o Silicone tubing that goes in pump 
o PDMS support piece for static control 
 Aluminum foil 6” x 4”(To prevent contamination of the bioreactor when mounting sample) 
 Two forceps 
 Time needed: at least 12 hours 
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Put together the bioreactor if necessary. Place everything inside the autoclave bag or completely cover 
with foil, and seal it. Make sure that the autoclave has enough water to run the cycle. Place the sealed 
autoclave bag in to the autoclave and run one cycle. Remove the bag from the autoclave and let it cool for 
at least 12 hours. Only open the bag inside a well-ventilated biosafety cabinet.  
 
Part 2. Biosafety cabinet setup 
 
In addition to sterilization, the biosafety cabinet needs to be setup before performing the experiment.  
 
1. Gather all materials needed for the experiment:  
a. Latex gloves 
b. Kim wipes 
c. 70% ethanol 
d. Pipette aid 
e. Pipettes  
f. Sterile Sutures 
g. Forceps 
h. Media, warmed to 37˚C in bath 
 Media required for the culturing of TEVGs as of 2/13/13 is high glucose, DMEM with 10% 
fetal bovine serum, 1% Pen-Strep, 1% glutamax, 1% nonessential amino acids, 1% sodium 
pyruvate 
i. Styrofoam tube rack for bioreactor glass tube 
j. Pump  
k. Cooled Autoclave bag with bioreactor, forceps, aluminum foil and silicone tubing 
l. Sterile latex gloves 
m. Tissue tubes 
 Only removed from incubator when needed for mounting 
2. Turn on hood and make sure that the glass window is raised to the height marked. 
3. Put on non-sterile gloves 
4. Clean the hood walls, surface, and vacuum tube with 70% ethanol. 
5. Spray everything with 70% ethanol before placing in the hood including your gloved hands and 
excluding the tissue tubes.  
6. Open autoclave bag inside hood 
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7. The placement of each object in the hood will aid in making everything easier. Figure below 
depicts the orientation recommended.  
a. Pipette aid, pipettes, forceps, and sutures in front to the right 
b. Media in the back right 
c. Tube rack with in the rear middle with glass tube 
d. Bioreactor and tissue tubes in the center. **Do not place bioreactor directly on hood 
surface, place bioreactor on sterile aluminum and glass tube in the tube rack.  
 
 
 
8. Replace non-sterile gloves with sterile gloves 
9. Slide tissue sample off the silicone mandrel onto needle mount of mobile arm. Suture tube onto 
needle using forceps and silk sutures, as shown in Appendix C.  
10. Place glass tube into stand and fill with 95 mL of cell media  
11. Put support piece connected to stopper into glass tube 
12. Prime the interior flow loop with the pump, and clamp each end with ratchet clamps as described 
in Appendix E.  
13. Place bioreactor in incubator (37C, 5% CO2) with silicone tubing running out the back to the 
pump, which is placed on top of the incubator. 
14. Close incubator door and run pump forward on speed Slow 7.5. 
15. Place two other tissue samples in separate petri dishes filled with media to serve as controls. 
16. Place these petri dishes in the incubator. 
17. Fix one tissue sample at this point with 10% neutral buffered formalin for 30 minutes. 
18. Vertically embed the sample in paraffin. 
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19. Run bioreactor for 48 hours. 
20. Perform staining.  
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Appendix G 
 
Estimated Cost of Bioreactor  
Item Cost (USD) 
1 Stopper 6.38 
2 male Luer to thread adapters 1.15 
1 glass tube 4.00 
2 barbed fittings 3.45 
2 Luer to needle mounts 0.48 
1 x .5 x 4 in. polycarbonate 1.28 
3 in. stainless steel screw 1.18 
4 O-rings 0.26 
Total: 18.18 
 
 
Estimated Cost of Cerulli et al. Bioreactor 
Item Cost (USD) 
Polycarbonate* 20.12 
2 male Luer to thread adapters 1.15 
1 thread to barb connector  1.15 
Female Luer to thread barb 0.40 
2 female Luer to needle mounts 0.48 
Neodymium magnet 0.27 
Steel bar Unknown 
Total: ~23.56 
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*Previous Bioreactor Dimensions + .25 in per Dimension 
for Manufacturing 
Part Dimensions (mm) mm
3
 in
3
 
Reservoir 
133.35  206128.76 12.58 
46.35 
  
33.35  
  
Top 
147.35 292441.49 17.84 
61.35 
  
32.35 
  
Mobile arm 
27.35 16216.43 0.99 
24.35 
  
24.35 
  
  
Total Size: 31.41 
  
Cost: 20.12 
 
